Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Edison Investment Research
Provider: Plunkett Research, Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

iCo Therapeutics Inc announces C$6.75 mln equity financing

Wednesday, 22 Jan 2014 08:42am EST 

iCo Therapeutics Inc:Issuance of an aggregate of up to 16,206,483 units of the company at a price of C$0.4165per unit for aggregate gross proceeds of about C$6.75 million.Says each unit is comprised of one common share of the company and three-quarter of one common share purchase warrant.Says each warrant is exercisable at a price of C$0.539and entitles the holder thereof to acquire one common share of the company for a period of five years following the closing of the offering.Says it intends to use the net proceeds of the Offering to finance the iDEAL Study and for general and administrative expenses.Says. 

Company Quote

0.0 +0.00%
10 Jul 2014